ESSA Pharma Inc. lost $0.64 per diluted share in fiscal year 2024. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters ESSA Pharma Inc. has filed alongside them.
FY2024 annual
EPS (Diluted)-$0.64
YoYn/m
Source SEC Filings (10-K/10-Q)Latest period Q3 FY2025, ended Jun 30, 2025ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
EPIX EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was ESSA Pharma Inc.'s diluted earnings per share in fiscal year 2024?
ESSA Pharma Inc. lost $0.64 per diluted share in fiscal year 2024.
How fast is ESSA Pharma Inc.'s diluted earnings per share growing?
ESSA Pharma Inc. (EPIX) reported a loss of $0.60 per diluted share in fiscal year 2023 and a loss of $0.64 per diluted share in fiscal year 2024. A growth rate is not meaningful here, because the earlier figure was zero or negative.
How has ESSA Pharma Inc.'s diluted earnings per share changed over the years?
Across the 6 fiscal years this page covers, ESSA Pharma Inc. (EPIX) diluted earnings per share went from -$1.51 in fiscal year 2019 to -$0.64 in fiscal year 2024.
What was ESSA Pharma Inc.'s diluted earnings per share in the most recent quarter?
ESSA Pharma Inc. (EPIX) reported -$0.09 in diluted earnings per share in Q3 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what ESSA Pharma Inc. (EPIX) reported on that line in every period on record.
